The Trump administration and AstraZeneca announced Friday they have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S.
The deal with AstraZeneca follows a similar pact with U.S. drugmaker Pfizer, which was announced late last month.
